Penobscot Investment Management Company, Inc. Gilead Sciences, Inc. Transaction History

Penobscot Investment Management Company, Inc.

$989 Million
Q2 2024

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$62.32 - $89.47 $168,264 - $241,569	2,700 New	2,700 $231,000
Q1 2022 May 11, 2022	SELL	$57.92 - $72.58 $163,334 - $204,675	-2,820 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$64.88 - $73.64 $182,961 - $207,664	2,820 New	2,820 $205,000
Q4 2020 Feb 08, 2021	SELL	$56.65 - $64.55 $190,344 - $216,888	-3,360 Closed	0 $0
Q1 2020 May 07, 2020	SELL	$62.63 - $80.22 $9,394 - $12,033	-150 Reduced 4.27%	3,360 $251,000
Q4 2019 Feb 04, 2020	SELL	$61.62 - $67.78 $7,394 - $8,133	-120 Reduced 3.31%	3,510 $228,000
Q3 2019 Nov 05, 2019	SELL	$62.51 - $69.0 $62,510 - $69,000	-1,000 Reduced 21.6%	3,630 $230,000
Q1 2019 May 13, 2019	SELL	$62.53 - $70.05 $6,878 - $7,705	-110 Reduced 2.32%	4,630 $301,000
Q4 2018 Feb 12, 2019	SELL	$60.54 - $79.0 $135,609 - $176,960	-2,240 Reduced 32.09%	4,740 $296,000
Q3 2018 Nov 01, 2018	SELL	$71.28 - $78.92 $4,989 - $5,524	-70 Reduced 0.99%	6,980 $539,000
Q4 2017 Feb 05, 2018	SELL	$71.15 - $83.52 $14,230 - $16,704	-200 Reduced 2.76%	7,050 $505,000
Q3 2017 Nov 02, 2017	BUY	$72.11 - $85.47 $522,797 - $619,657	7,250	7,250 $587,000

Others Institutions Holding GILD

# of Institutions

1,893

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.04M

Black Rock Inc. New York, NY

121M
Shares

$10.6 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.2 Billion
0.15% of portfolio
Capital World Investors Los Angeles, CA

76.2M
Shares

$6.72 Billion
0.88% of portfolio
Capital Research Global Investors Los Angeles, CA

60.4M
Shares

$5.32 Billion
0.94% of portfolio
State Street Corp Boston, MA

59.3M
Shares

$5.23 Billion
0.18% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Penobscot Investment Management Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Penobscot Investment Management Company, Inc. with notifications on news.

Account